View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Macerich Declares the Quarterly Dividend on Its Common Shares

Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on June 3, 2024, to stockholders of record at the close of business on May 20, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U...

 PRESS RELEASE

Macerich Celebrates Earth Month With ‘You Pledge We Plant’ Campaign, I...

Macerich Celebrates Earth Month With ‘You Pledge We Plant’ Campaign, Industry Recognition Campaign To Plant 100,000+ Trees to Support Reforestation, Urban Forestry Retail REIT Named Green Lease Leader, Honored Among ‘America’s Most Responsible Companies’ SANTA MONICA, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of high-quality retail real estate in top markets, is celebrating Earth Month with its “You Pledge We Plant” campaign to plant more than 100,000 trees across the country. In partnership with , Maceric...

 PRESS RELEASE

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conf...

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, . Once registered, a dial-i...

Biohaven Ltd: 1 director

A director at Biohaven Ltd bought 25,503 shares at 39.179USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

 PRESS RELEASE

Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Co...

Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th DENVER, April 16, 2024 (GLOBE NEWSWIRE) -- After the close of market trading on Tuesday, May 7, 2024, Angi Inc. (NASDAQ: ANGI) will post its first quarter results at . On Wednesday May 8, 2024, at 8:30 a.m. ET, Angi Inc. and IAC will host a conference call to answer questions regarding the companies’ respective first quarter results. The live audiocast and replay will be open to the public through the investor relations section of the Angi site at . About Angi Inc. Angi (NASDAQ: ANGI) helps...

 PRESS RELEASE

Angi Appoints Jeff Kip as CEO

Angi Appoints Jeff Kip as CEO DENVER, April 08, 2024 (GLOBE NEWSWIRE) -- Angi (NASDAQ: ANGI), the leading and most comprehensive solution for all home care needs, today announced the appointment of Angi President and long-time IAC and Angi executive Jeff Kip to CEO, succeeding Joey Levin. As CEO, Mr. Kip will lead Angi’s executive team, overseeing strategy and daily management of the company. Mr. Levin, CEO of IAC, will continue as Chairman of the Angi Board of Directors. All changes are effective immediately. “Through multiple roles, Jeff Kip has been a student of the Angi business, fir...

 PRESS RELEASE

Macerich Schedules First Quarter 2024 Earnings Release and Conference ...

Macerich Schedules First Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules First Quarter 2024 Earnings Release and Conference Call WHEN: Earnings Results will be released before market open on Tuesday, April 30, 2024. Management will hold a conference call at 10:00 am Pacific Time (1:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in numb...

Macerich Co: 1 director

A director at Macerich Co sold 95,000 shares at 17.152USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Texas Pacific Land Corp: 1 director

A director at Texas Pacific Land Corp bought 12 shares at 1,679.180USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Opko Health Inc: 1 director

A director at Opko Health Inc bought 500,000 shares at 0.874USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 18, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 14, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at . This year’s event will consist of 1-on-1 / small group meetings, analy...

Fleetcor Technologies Inc: 1 director

A director at Fleetcor Technologies Inc sold/sold after exercising options 7,004 shares at 290.455USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...

 PRESS RELEASE

Macerich Marks 30 Years as Public Company, Rings Closing Bell at New Y...

Macerich Marks 30 Years as Public Company, Rings Closing Bell at New York Stock Exchange New Company President & CEO Jack Hsieh Joined by Senior Executives for Celebratory Milestone SANTA MONICA, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of high-quality retail and mixed-use properties in top markets, today marked its 30th anniversary as a public company by ringing the closing bell at the New York Stock Exchange. Jack Hsieh, who took the reins as Macerich President and CEO on March 1, 2024, was joined by a ...

 PRESS RELEASE

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX...

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal antibodies and minimal anti-drug antibodies WESTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced results from a Phase 1 clinical study of SAR441236, its trispecific broadly neutralizing ant...

 PRESS RELEASE

The Macerich Company Announces Grant of Employment Inducement Award in...

The Macerich Company Announces Grant of Employment Inducement Award in Connection with Appointment of Jackson Hsieh as President and Chief Executive Officer SANTA MONICA, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company”) announced that it granted two inducement equity awards to Jackson Hsieh on March 1, 2024, the effective date of Mr. Hsieh’s appointment as President and Chief Executive Officer of the Company, pursuant to the employment agreement entered into between the Company and Mr. Hsieh effective March 1, 2024. The awards were granted in acc...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch